Cargando…
Multi-label classification for multi-drug resistance prediction of Escherichia coli
Antimicrobial resistance (AMR) is a global health and development threat. In particular, multi-drug resistance (MDR) is increasingly common in pathogenic bacteria. It has become a serious problem to public health, as MDR can lead to the failure of treatment of patients. MDR is typically the result o...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research Network of Computational and Structural Biotechnology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918850/ https://www.ncbi.nlm.nih.gov/pubmed/35317240 http://dx.doi.org/10.1016/j.csbj.2022.03.007 |
_version_ | 1784668817869242368 |
---|---|
author | Ren, Yunxiao Chakraborty, Trinad Doijad, Swapnil Falgenhauer, Linda Falgenhauer, Jane Goesmann, Alexander Schwengers, Oliver Heider, Dominik |
author_facet | Ren, Yunxiao Chakraborty, Trinad Doijad, Swapnil Falgenhauer, Linda Falgenhauer, Jane Goesmann, Alexander Schwengers, Oliver Heider, Dominik |
author_sort | Ren, Yunxiao |
collection | PubMed |
description | Antimicrobial resistance (AMR) is a global health and development threat. In particular, multi-drug resistance (MDR) is increasingly common in pathogenic bacteria. It has become a serious problem to public health, as MDR can lead to the failure of treatment of patients. MDR is typically the result of mutations and the accumulation of multiple resistance genes within a single cell. Machine learning methods have a wide range of applications for AMR prediction. However, these approaches typically focus on single drug resistance prediction and do not incorporate information on accumulating antimicrobial resistance traits over time. Thus, identifying multi-drug resistance simultaneously and rapidly remains an open challenge. In our study, we could demonstrate that multi-label classification (MLC) methods can be used to model multi-drug resistance in pathogens. Importantly, we found the ensemble of classifier chains (ECC) model achieves accurate MDR prediction and outperforms other MLC methods. Thus, our study extends the available tools for MDR prediction and paves the way for improving diagnostics of infections in patients. Furthermore, the MLC methods we introduced here would contribute to reducing the threat of antimicrobial resistance and related deaths in the future by improving the speed and accuracy of the identification of pathogens and resistance. |
format | Online Article Text |
id | pubmed-8918850 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Research Network of Computational and Structural Biotechnology |
record_format | MEDLINE/PubMed |
spelling | pubmed-89188502022-03-21 Multi-label classification for multi-drug resistance prediction of Escherichia coli Ren, Yunxiao Chakraborty, Trinad Doijad, Swapnil Falgenhauer, Linda Falgenhauer, Jane Goesmann, Alexander Schwengers, Oliver Heider, Dominik Comput Struct Biotechnol J Research Article Antimicrobial resistance (AMR) is a global health and development threat. In particular, multi-drug resistance (MDR) is increasingly common in pathogenic bacteria. It has become a serious problem to public health, as MDR can lead to the failure of treatment of patients. MDR is typically the result of mutations and the accumulation of multiple resistance genes within a single cell. Machine learning methods have a wide range of applications for AMR prediction. However, these approaches typically focus on single drug resistance prediction and do not incorporate information on accumulating antimicrobial resistance traits over time. Thus, identifying multi-drug resistance simultaneously and rapidly remains an open challenge. In our study, we could demonstrate that multi-label classification (MLC) methods can be used to model multi-drug resistance in pathogens. Importantly, we found the ensemble of classifier chains (ECC) model achieves accurate MDR prediction and outperforms other MLC methods. Thus, our study extends the available tools for MDR prediction and paves the way for improving diagnostics of infections in patients. Furthermore, the MLC methods we introduced here would contribute to reducing the threat of antimicrobial resistance and related deaths in the future by improving the speed and accuracy of the identification of pathogens and resistance. Research Network of Computational and Structural Biotechnology 2022-03-10 /pmc/articles/PMC8918850/ /pubmed/35317240 http://dx.doi.org/10.1016/j.csbj.2022.03.007 Text en © 2022 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Research Article Ren, Yunxiao Chakraborty, Trinad Doijad, Swapnil Falgenhauer, Linda Falgenhauer, Jane Goesmann, Alexander Schwengers, Oliver Heider, Dominik Multi-label classification for multi-drug resistance prediction of Escherichia coli |
title | Multi-label classification for multi-drug resistance prediction of Escherichia coli |
title_full | Multi-label classification for multi-drug resistance prediction of Escherichia coli |
title_fullStr | Multi-label classification for multi-drug resistance prediction of Escherichia coli |
title_full_unstemmed | Multi-label classification for multi-drug resistance prediction of Escherichia coli |
title_short | Multi-label classification for multi-drug resistance prediction of Escherichia coli |
title_sort | multi-label classification for multi-drug resistance prediction of escherichia coli |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918850/ https://www.ncbi.nlm.nih.gov/pubmed/35317240 http://dx.doi.org/10.1016/j.csbj.2022.03.007 |
work_keys_str_mv | AT renyunxiao multilabelclassificationformultidrugresistancepredictionofescherichiacoli AT chakrabortytrinad multilabelclassificationformultidrugresistancepredictionofescherichiacoli AT doijadswapnil multilabelclassificationformultidrugresistancepredictionofescherichiacoli AT falgenhauerlinda multilabelclassificationformultidrugresistancepredictionofescherichiacoli AT falgenhauerjane multilabelclassificationformultidrugresistancepredictionofescherichiacoli AT goesmannalexander multilabelclassificationformultidrugresistancepredictionofescherichiacoli AT schwengersoliver multilabelclassificationformultidrugresistancepredictionofescherichiacoli AT heiderdominik multilabelclassificationformultidrugresistancepredictionofescherichiacoli |